Depression Research Today is a free monthly online journal that collates and summarizes the latest research about Depression, including details on clinical depression, medication, symptoms, treatment, counselling, therapy.

Volume 2 (2005), Issue 4 (April)

1. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
   Breast Cancer Res Treat, 90(2): 139-48. [Abstract] [Full-text]
2. Prospective study of risk factors for attempted suicide among patients with DSM-IV major depressive disorder.
   Br J Psychiatry, 186: 314-8. [Abstract] [Full-text]
3. Neurological findings in late-onset depressive disorder: comparison of individuals with and without depression.
   Br J Psychiatry, 186: 308-13. [Abstract] [Full-text]
4. Negative self-schemas and the onset of depression in women: longitudinal study.
   Br J Psychiatry, 186: 302-7. [Abstract] [Full-text]
5. HIV-related risk factors associated with commercial sex among female migrants in China.
   Health Care Women Int, 26(2): 134-48. [Abstract] [Full-text]
6. Everyday competence and depressive symptoms: social support and sense of control as mediators or moderators?
   Aging Ment Health, 9(2): 177-83. [Abstract] [Full-text]
7. The vascular depression hypothesis: the influence of age on the relationship between cerebrovascular risk factors and depressive symptoms in community dwelling elders.
   Aging Ment Health, 9(2): 146-52. [Abstract] [Full-text]
8. Down and drowsy? Do apathetic nursing home residents experience low quality of life?
   Aging Ment Health, 9(2): 135-41. [Abstract] [Full-text]
9. Acute cortisol administration modulates EEG alpha asymmetry in volunteers: relevance to depression.
   Biol Psychol, 69(2): 181-93. [Abstract] [Full-text]
10. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides.
    Brain Res, 1041(1): 19-28. [Abstract] [Full-text]
11. Stability of DSM-IV criterion symptoms for major depressive disorder.
    J Psychiatr Res, 39(4): 415-20. [Abstract] [Full-text]
12. Anatomical MRI study of corpus callosum in unipolar depression.
    J Psychiatr Res, 39(4): 347-54. [Abstract] [Full-text]
13. Indicators of psychological distress in postacute spinal cord injured individuals.
    Spinal Cord, 43(4): 223-9. [Abstract] [Full-text]
14. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
    Arch Gen Psychiatry, 62(4): 417-22. [Abstract] [Full-text]
15. Cognitive therapy vs medications in the treatment of moderate to severe depression.
    Arch Gen Psychiatry, 62(4): 409-16. [Abstract] [Full-text]
16. Neuroanatomic correlates of psychopathologic components of major depressive disorder.
    Arch Gen Psychiatry, 62(4): 397-408. [Abstract] [Full-text]
17. Alterations in regional cerebral glucose metabolism across waking and non-rapid eye movement sleep in depression.
    Arch Gen Psychiatry, 62(4): 387-96. [Abstract] [Full-text]
18. Natural killer cells and lymphocytes increase in women with breast cancer following massage therapy.
    Int J Neurosci, 115(4): 495-510. [Abstract] [Full-text]
19. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.
    J Am Coll Cardiol, 45(7): 1090-5. [Abstract] [Full-text]
20. Marked depression and anxiety in patients with functional dysphonia.
    Psychiatry Res, 134(1): 85-91. [Abstract] [Full-text]
21. Affect-modulated startle in adults with childhood-onset depression: relations to bipolar course and number of lifetime depressive episodes.
    Psychiatry Res, 134(1): 11-25. [Abstract] [Full-text]
22. The prevalence and impact of alcohol problems in major depression: a systematic review.
    Am J Med, 118(4): 330-41. [Abstract] [Full-text]
23. Comparison of the prevalence and risk factors for depressive symptoms among elderly nursing home residents in Taiwan and Hong Kong.
    Int J Geriatr Psychiatry, 20(4): 315-21. [Abstract] [Full-text]
24. The sensitivity of somatic symptoms in post-stroke depression: a discriminant analytic approach.
    Int J Geriatr Psychiatry, 20(4): 358-62. [Abstract] [Full-text]
25. The factor structure of the Hospital Anxiety and Depression Scale in older individuals with acquired amputations: a comparison of four models using confirmatory factor analysis.
    Int J Geriatr Psychiatry, 20(4): 344-9. [Abstract] [Full-text]
26. The effects of psychosocial methods on depressed, aggressive and apathetic behaviors of people with dementia: a systematic review.
    Int J Geriatr Psychiatry, 20(4): 301-14. [Abstract] [Full-text]
27. Prevalence and correlates of depression in late life: a population based study from a rural Greek town.
    Int J Geriatr Psychiatry, 20(4): 350-7. [Abstract] [Full-text]
28. A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients.
    Psychiatr Serv, 56(4): 487-9. [Abstract] [Full-text]
29. Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs.
    Psychiatr Serv, 56(4): 468-74. [Abstract] [Full-text]
30. Abnormal patterns of maternal behavior in a genetic animal model of depression.
    Physiol Behav, 84(4): 607-15. [Abstract] [Full-text]
31. Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions.
    Physiol Behav, 84(4): 571-7. [Abstract] [Full-text]
32. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
    Curr Med Res Opin, 21(3): 345-56. [Abstract] [Full-text]
33. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Fundam Clin Pharmacol, 19(2): 133-46. [Abstract] [Full-text]
34. Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression.
    Hum Psychopharmacol, 20(3): 163-74. [Abstract] [Full-text]
35. A meta-analytic review of verbal fluency deficits in depression.
    J Clin Exp Neuropsychol, 27(1): 78-101. [Abstract] [Full-text]
36. The impact of neuropsychological impairment and depression on health-related quality of life in HIV-infection.
    J Clin Exp Neuropsychol, 27(1): 1-15. [Abstract] [Full-text]
37. Gender differences in the relation between social support, problems in parent-offspring communication, and depression and anxiety.
    Soc Sci Med, 60(11): 2549-59. [Abstract] [Full-text]
38. The impact of own and spouse's urinary incontinence on depressive symptoms.
    Soc Sci Med, 60(11): 2537-48. [Abstract] [Full-text]
39. Depression and concomitant diseases in a Turkish geriatric outpatient setting.
    Arch Gerontol Geriatr, 40(3): 307-15. [Abstract] [Full-text]
40. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study.
    Arch Gerontol Geriatr, 40(3): 275-85. [Abstract] [Full-text]
41. Stability and discriminative power of the Young Schema-Questionnaire in a Dutch clinical versus non-clinical population.
    J Behav Ther Exp Psychiatry, 36(2): 129-44. [Abstract] [Full-text]
42. Differentiating symptoms of social anxiety and depression in adults with social anxiety disorder.
    J Behav Ther Exp Psychiatry, 36(2): 99-109. [Abstract] [Full-text]
43. Anxiety, depression and psychotropic medication use in patients with persistent upper and lower gastrointestinal symptoms.
    Aliment Pharmacol Ther, 21(8): 1001-6. [Abstract] [Full-text]
44. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men.
    J Am Geriatr Soc, 53(4): 636-42. [Abstract] [Full-text]
45. The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health Study.
    J Am Geriatr Soc, 53(4): 569-75. [Abstract] [Full-text]
46. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders.
    Chest, 127(4): 1205-11. [Abstract] [Full-text]
47. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects.
    Biol Psychiatry, 57(8): 935-7. [Abstract] [Full-text]
48. The role of stress-induced cortisol in the relationship between depression and decreased bone mineral density.
    Biol Psychiatry, 57(8): 911-7. [Abstract] [Full-text]
49. Partial serotonergic denervation decreases progenitor cell proliferation in the adult rat hippocampus, but has no effect on rat behavior in the forced swimming test.
    Pharmacol Biochem Behav, 80(4): 549-56. [Abstract] [Full-text]
50. The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression.
    Eur Neuropsychopharmacol, 15(3): 253-62. [Abstract] [Full-text]
51. Primidone is associated with interictal depression in patients with epilepsy.
    Epilepsy Behav, 6(3): 413-6. [Abstract] [Full-text]
52. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs.
    Epilepsy Behav, 6(3): 360-5. [Abstract] [Full-text]
53. Prevalence of and risk factors for anxiety and depressive disorders in Nigerian adolescents with epilepsy.
    Epilepsy Behav, 6(3): 342-7. [Abstract] [Full-text]
54. Should neurologists be trained to recognize and treat comorbid depression of neurologic disorders? Yes.
    Epilepsy Behav, 6(3): 303-11. [Abstract] [Full-text]
55. The relationships between symptom dimensions and dysphoria in schizophrenia.
    Schizophr Res, 75(1): 83-96. [Abstract] [Full-text]
56. Suicidal behavior in schizophrenia and depression: a comparison.
    Schizophr Res, 75(1): 77-81. [Abstract] [Full-text]
57. Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors.
    J Affect Disord, 86(1): 99-104. [Abstract] [Full-text]
58. Major depressive disorder in Latin America: the relationship between depression severity, painful somatic symptoms, and quality of life.
    J Affect Disord, 86(1): 93-8. [Abstract] [Full-text]
59. The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients.
    J Affect Disord, 86(1): 87-91. [Abstract] [Full-text]
60. Course profiles of early- and adult-onset depression.
    J Affect Disord, 86(1): 81-6. [Abstract] [Full-text]
61. Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes.
    J Affect Disord, 86(1): 75-9. [Abstract] [Full-text]
62. Dopaminergic mechanism of antidepressant action in depressed patients.
    J Affect Disord, 86(1): 37-45. [Abstract] [Full-text]
63. Is low mood an adaptation? Evidence for subtypes with symptoms that match precipitants.
    J Affect Disord, 86(1): 27-35. [Abstract] [Full-text]
64. Seasonality in a community sample of bipolar, unipolar and control subjects.
    J Affect Disord, 86(1): 19-25. [Abstract] [Full-text]
65. Activation in dorsolateral prefrontal cortex in response to maternal criticism and praise in recovered depressed and healthy control participants.
    Biol Psychiatry, 57(7): 809-12. [Abstract] [Full-text]
66. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.
    Biol Psychiatry, 57(7): 716-25. [Abstract] [Full-text]
67. The effectiveness of psychological treatments for treatment-resistant depression: a systematic review.
    Acta Psychiatr Scand, 111(5): 331-40. [Abstract] [Full-text]
68. Hopelessness and suicidal ideation among adolescents in two cultures.
    J Child Psychol Psychiatry, 46(4): 364-72. [Abstract] [Full-text]
69. Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting.
    Depress Anxiety, 21(1): 26-32. [Abstract] [Full-text]
70. Investigation of mood-congruent false and true memory recognition in depression.
    Depress Anxiety, 21(1): 9-17. [Abstract] [Full-text]
71. Motor and functional recovery in patients with post-stroke depression.
    Disabil Rehabil, 27(4): 170-5. [Abstract] [Full-text]
72. Depression in adults with disabilities, in primary care.
    Disabil Rehabil, 27(3): 117-23. [Abstract] [Full-text]
73. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
    Gynecol Endocrinol, 20(2): 64-7. [Abstract] [Full-text]
74. Ratings of positive and depressive emotion as predictors of mortality in coronary patients.
    Int J Cardiol, 100(2): 213-6. [Abstract] [Full-text]
75. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder.
    Psychiatry Clin Neurosci, 59(2): 140-5. [Abstract] [Full-text]
76. Understanding and treating depression among cancer patients.
    Int J Gynecol Cancer, 15(2): 203-8. [Abstract] [Full-text]
77. Depressive symptoms and mental health service utilization among persons with limb loss: results of a national survey.
    Arch Phys Med Rehabil, 86(4): 650-8. [Abstract] [Full-text]
78. Repetitive transcranial magnetic stimulation (rTMS) at high and low frequency: an efficacious therapy for major drug-resistant depression?
    Clin Neurophysiol, 116(5): 1062-71. [Abstract] [Full-text]
79. Thirty-six month outcome data from a trial of counselling with chronically depressed patients in a general practice setting.
    Psychol Psychother, 78: 127-38. [Abstract] [Full-text]
80. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences.
    Br J Clin Psychol, 44: 113-25. [Abstract] [Full-text]
81. Coping with depression and vulnerability to mania: a factor analytic study of the Nolen-Hoeksema (1991) Response Styles Questionnaire.
    Br J Clin Psychol, 44: 99-112. [Abstract] [Full-text]
82. Visual hallucinations in psychiatric conditions: appraisals and their relationship to distress.
    Br J Clin Psychol, 44: 77-87. [Abstract] [Full-text]
83. Sentence completion test for depression (SCD): an idiographic measure of depressive thinking.
    Br J Clin Psychol, 44: 29-46. [Abstract] [Full-text]
84. Thought suppression and cognitive vulnerability to depression.
    Br J Clin Psychol, 44: 1-14. [Abstract] [Full-text]
85. The longitudinal effects of work-family conflict and positive spillover on depressive symptoms among dual-earner couples.
    J Occup Health Psychol, 10(2): 138-54. [Abstract] [Full-text]
86. The impact of deployment length and experience on the well-being of male and female soldiers.
    J Occup Health Psychol, 10(2): 121-37. [Abstract] [Full-text]
87. Work stress, substance use, and depression among young adult workers: an examination of main and moderator effect model.
    J Occup Health Psychol, 10(2): 83-96. [Abstract] [Full-text]
88. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Int Immunopharmacol, 5(6): 1069-76. [Abstract] [Full-text]
89. Stressful life events, depression and demoralization as risk factors for acute coronary heart disease.
    Psychother Psychosom, 74(3): 179-84. [Abstract] [Full-text]
90. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
    Psychother Psychosom, 74(3): 173-8. [Abstract] [Full-text]
91. Operative delivery and postnatal depression: a cohort study.
    BMJ, 330(7496): 879. [Abstract] [Full-text]
92. Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology.
    Addict Behav, 30(4): 829-40. [Abstract] [Full-text]
93. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.
    Addict Behav, 30(4): 807-14. [Abstract] [Full-text]
94. Strategies for producing faster acting antidepressants.
    Drug Discov Today, 10(8): 578-85. [Abstract] [Full-text]
95. Polymorphisms of the cholecystokinin gene promoter region in suicide victims in Japan.
    Forensic Sci Int, 150(1): 85-90. [Abstract] [Full-text]
96. Possible selves in chronic pain: self-pain enmeshment, adjustment and acceptance.
    Pain, 115(1): 84-94. [Abstract] [Full-text]
97. Can a seizure help? The public's attitude toward electroconvulsive therapy.
    Psychiatry Res, 134(2): 205-9. [Abstract] [Full-text]
98. A dimensional approach to personality in atypical depression.
    Psychiatry Res, 134(2): 161-7. [Abstract] [Full-text]
99. Differences in coping style and locus of control between older and younger patients with head and neck cancer.
    Clin Otolaryngol, 30(2): 186-92. [Abstract] [Full-text]
100. Depressive symptomatology, exposure to violence, and the role of social capital among African American adolescents.
     Am J Orthopsychiatry, 75(2): 262-74. [Abstract] [Full-text]
101. Testing a model of suicide ideation in college students.
     Suicide Life Threat Behav, 35(2): 181-92. [Abstract] [Full-text]
102. Correlates of suicide in the older adult population in Quebec.
     Suicide Life Threat Behav, 35(1): 91-105. [Abstract] [Full-text]
103. The mediating roles of anxiety depression, and hopelessness on adolescent suicidal behaviors.
     Suicide Life Threat Behav, 35(1): 14-34. [Abstract] [Full-text]
104. Aspects of suicidal behavior, depression, and treatment in college students: results from the spring 2000 national college health assessment survey.
     Suicide Life Threat Behav, 35(1): 3-13. [Abstract] [Full-text]
105. The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding.
     Pharmacotherapy, 25(3): 411-25. [Abstract] [Full-text]
106. Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder.
     Pharmacotherapy, 25(3): 396-410. [Abstract] [Full-text]
107. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis.
     Ann Pharmacother, 39(5): 803-9. [Abstract] [Full-text]
108. Paraprofessionals for anxiety and depressive disorders.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
109. Physical measures for treating depression in dialysis patients.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
110. Antidepressant prevention of postnatal depression.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
111. Acupuncture for depression.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
112. St John's wort for depression.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
113. Race and vascular depression risk in community-dwelling older adults.
     Am J Geriatr Psychiatry, 13(4): 329-32. [Abstract] [Full-text]
114. Effects of previous major depressive illness on cognition in Alzheimer disease patients.
     Am J Geriatr Psychiatry, 13(4): 312-8. [Abstract] [Full-text]
115. Predictors of health functioning in two high-risk groups of smokers.
     Drug Alcohol Depend, 78(2): 169-75. [Abstract] [Full-text]
116. Mediating links between maternal depression and offspring psychopathology: the importance of independent data.
     J Child Psychol Psychiatry, 46(5): 490-9. [Abstract] [Full-text]
117. Towards a family process model of maternal and paternal depressive symptoms: exploring multiple relations with child and family functioning.
     J Child Psychol Psychiatry, 46(5): 479-89. [Abstract] [Full-text]
118. Applying service-learning through a community-academic partnership: depression screening at a federally funded community health center.
     Educ Health (Abingdon), 17(3): 313-22. [Abstract] [Full-text]
119. Psychosocial work characteristics and incidence of newly diagnosed depression: a prospective cohort study of three different models.
     Soc Sci Med, 61(1): 111-22. [Abstract] [Full-text]
120. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients.
     Arch Med Res, 36(2): 159-65. [Abstract] [Full-text]
121. Is there really a 'J-shaped' curve in the association between alcohol consumption and symptoms of depression and anxiety? Findings from the Mater-University Study of Pregnancy and its outcomes.
     Addiction, 100(5): 643-51. [Abstract] [Full-text]
122. Association of the apolipoprotein A-IV: 360 Gln/His polymorphism with cerebrovascular disease, obesity, and depression in a Brazilian elderly population.
     Am J Med Genet B Neuropsychiatr Genet, 135(1): 65-8. [Abstract] [Full-text]
123. Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders.
     Am J Med Genet B Neuropsychiatr Genet, 135(1): 85-93. [Abstract] [Full-text]
124. Usefulness of the nurse-assisted screening and psychiatric referral program.
     Cancer, 103(9): 1949-56. [Abstract] [Full-text]
125. Association analysis of monoamine genes with measures of depression and anxiety in a selected community sample of siblings.
     Am J Med Genet B Neuropsychiatr Genet, 135(1): 33-7. [Abstract] [Full-text]
126. The association of obesity, cytokine levels, and depressive symptoms with diverse measures of fatigue in healthy subjects.
     Arch Intern Med, 165(8): 910-5. [Abstract] [Full-text]
127. Functional disability, disability transitions, and depressive symptoms in late life.
     J Aging Health, 17(3): 263-92. [Abstract] [Full-text]
128. Blunted response to cocaine in the Flinders hypercholinergic animal model of depression.
     Neuroscience, 132(4): 1159-71. [Abstract] [Full-text]
129. Screening for major depression in epilepsy with common self-report depression inventories.
     Epilepsia, 46(5): 731-5. [Abstract] [Full-text]
130. Depression and anxiety disorders in pediatric epilepsy.
     Epilepsia, 46(5): 720-30. [Abstract] [Full-text]
131. Factors affecting pain in intravenous catheter placement: role of depression illness.
     Int J Clin Pract, 59(3): 276-80. [Abstract] [Full-text]
132. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
     Int J Clin Pract, 59(3): 268-75. [Abstract] [Full-text]
133. Depression among female family planning patients: prevalence, risk factors, and use of mental health services.
     J Womens Health (Larchmt), 14(3): 225-32. [Abstract] [Full-text]
134. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer.
     J Clin Oncol, 23(13): 3052-60. [Abstract] [Full-text]
135. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity.
     Biol Psychiatry, 57(9): 1068-72. [Abstract] [Full-text]
136. Families at high and low risk for depression: a three-generation startle study.
     Biol Psychiatry, 57(9): 953-60. [Abstract] [Full-text]
137. Characteristics of internalizing and externalizing disorders in medication-naive, clinically referred children with attention deficit hyperactivity disorder, combined type and dysthymic disorder.
     Aust N Z J Psychiatry, 39(5): 359-65. [Abstract] [Full-text]

© 2004-2012 Depression Research Today. All Rights Reserved.